Working… Menu

Chemotherapy Combination With Local Radiotherapy and rhGM-CSF for Oligometastatic Stage IV NSCLC Patients (CRAGMOLC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03489616
Recruitment Status : Unknown
Verified March 2018 by Jinming Yu, Shandong Cancer Hospital and Institute.
Recruitment status was:  Recruiting
First Posted : April 5, 2018
Last Update Posted : April 5, 2018
Information provided by (Responsible Party):
Jinming Yu, Shandong Cancer Hospital and Institute